Literature DB >> 14652398

Use of a functional temporary prosthesis in a two-stage approach to infection at the site of a total hip arthroplasty.

Gracia Etienne1, Barry Waldman, Amar D Rajadhyaksha, Phillip S Ragland, Michael A Mont.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652398     DOI: 10.2106/00004623-200300004-00011

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  6 in total

1.  Septic versus aseptic hip revision: how different?

Authors:  Carlo Luca Romanò; Delia Romanò; Nicola Logoluso; Enzo Meani
Journal:  J Orthop Traumatol       Date:  2010-09-02

2.  Staged custom, intramedullary antibiotic spacers for severe segmental bone loss in infected total hip arthroplasty.

Authors:  Atul F Kamath; Okechukwu Anakwenze; Gwo-Chin Lee; Charles L Nelson
Journal:  Adv Orthop       Date:  2011-08-17

3.  Two-Stage Revision Arthroplasty for Periprosthetic Hip Infection: Mean Follow-Up of Ten Years.

Authors:  Szu-Yuan Chen; Chi-Chien Hu; Chun-Chieh Chen; Yu-Han Chang; Pang-Hsin Hsieh
Journal:  Biomed Res Int       Date:  2015-04-29       Impact factor: 3.411

4.  Temporary total hip arthroplasty-like spacer for treating an infected periprosthetic femoral fracture using a long stem: A case report.

Authors:  Youngwoo Kim; Yoshiaki Katsura; Nina Kasahara; Takashi Kasahara; Masashi Kanamura; Keiichi Kawanabe
Journal:  Int J Surg Case Rep       Date:  2017-03-22

5.  Patient-reported Outcome Measures of Revision Total Hip Arthroplasty for Prosthetic Joint Infection is not Inferior to Aseptic Revision Total Hip Arthroplasty.

Authors:  Jbt Lim; H N Pang; Kjd Tay; S L Chia; S J Yeo; N N Lo
Journal:  Malays Orthop J       Date:  2020-11

6.  The results of screw augmentation of acetabular cement spacers for the treatment of periprosthetic hip joint infection.

Authors:  Jing-Yao Jin; Taek-Rim Yoon; Kyung-Soon Park; Sheng-Yu Jin; Dong-Min Jung; Qing-Song Li
Journal:  J Orthop Surg Res       Date:  2020-09-29       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.